ArticleJAC-antimicrobial resistance2026

Promethazine use and QT prolongation risk during treatment with a shortened all-oral regimen for MDR/RR-TB.

Edmund Q L Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.